New Weight Loss Product!!!

[AASraw]

What is NA931?​

For a peptide manufacturer, NA-931 is a new and promising weight loss product like GLP-1 based obesity drug in the market. But right now it is still under development for the treatment of obesity and type 2 diabetes. NA-931 is rather new product for weight loss, so it will not as popular as Tirzepatide which already got approved by FDA.

NA-931 VS Semaglutide VS Tirzepatide VS Retatrutide​

NA-931 is developed as a oral obesity drug. Not like other GLP-1-based weight loss drug such as Tirzepatide, Semaglutide and Retatrutide in the market, NA931 will cause less side effects. As the studies stated, participants who take NA-931 will have less possible to experience gastrointestinal-related adverse like nausea, vomiting, diarrhea, and constipation. Besides, for its unique mechanism of IGF-1 activation, NA-931 can help to loss weight while preserve muscle mass. You will not experience “Ozempic face” side effect.